In Vitro Evaluation of Recombinant Bone Morphogenetic Protein-2 Bioactivity for Regenerative Medicine

Tissue Eng Part C Methods. 2019 Sep;25(9):553-559. doi: 10.1089/ten.TEC.2019.0156.

Abstract

This work is a systematic evaluation of the experimental parameters of the most widely used in vitro recombinant human bone morphogenetic protein-2 (rhBMP-2) activity assays. The variations in assays reported in the literature have challenged the reproducibility and translation of work using rhBMP-2 as a bone-inducing growth factor. By elucidating the effect of model cell line on the dose-dependent alkaline phosphatase response to rhBMP-2 induction and by establishing a correlation between protein activity and protein concentration by enzyme-linked immunosorbent assay using commercially available rhBMP-2, this work is a significant step toward developing an in vitro-in vivo correlation between quantified activity and clinical efficacy.

Keywords: BMP-2; alkaline phosphatase activity; bioactivity; bone regeneration.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Biological Assay*
  • Bone Morphogenetic Protein 2* / biosynthesis
  • Bone Morphogenetic Protein 2* / chemistry
  • Bone Morphogenetic Protein 2* / genetics
  • Bone Morphogenetic Protein 2* / pharmacology
  • Cell Line
  • Drug Evaluation
  • Humans
  • Mice
  • Protein Stability
  • Recombinant Proteins / biosynthesis
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / genetics
  • Recombinant Proteins / pharmacology
  • Regenerative Medicine

Substances

  • BMP2 protein, human
  • Bone Morphogenetic Protein 2
  • Recombinant Proteins